Get all your news in one place.
100's of premium titles.
One app.
Start reading
Zenger
Zenger
World
Abigail Klein Leichman

PhaseV Aims To Revolutionize Drug Development With AI And Machine Learning

American-Israeli startup PhaseV is on a mission to overcome one of the most significant challenges of drug development: the clinical trial phase, the longest and most expensive part of the process. 

A recent Deloitte report reveals that, on average, a single new drug takes $2.3 billion and seven years to develop.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.